DIRECT INVESTMENTS

Last updated on 17 September 2026. This list is updated periodically. As at the date of last update, there are 94 acceptable direct investments. Not all are listed, as some have chosen not to be included, for example where they are not currently open to investment.

If your company is an acceptable direct investment and you would like to be included in this list, please contact us at aipacceptableinvestments@investnz.govt.nz.

RespirAq Limited

Valid Investment Period expiry date: 1 September 2027
Total amount seeking: $2,000,000
Investment instrument: Convertible loan note
Type of capital: Start-up Capital

RespirAq is a New Zealand medtech company developing a breakthrough water-free active humidification system for respiratory care. With FDA Breakthrough Device Designation and a defined 510(k) pathway, RespirAq is progressing toward US regulatory submission and commercialisation. The technology addresses key limitations of conventional humidification, including condensation, infection risk and complexity. RespirAq is engaging with global respiratory-care companies and building toward US market entry and international expansion.

Website: www.respiraq.com
Contact: sandra@respiraq.com

Dot Ingredients Limited

Valid Investment Period expiry date: 14 August 2027
Total amount seeking: $3,500,000
Investment instrument: Issuing new shares (i.e. equity) 
Type of capital: Start-up Capital

Dot makes critical ingredients for cosmetics, pharmaceuticals and food that are sustainable, globally-available, cheaper than current options, and yet don’t contribute to deforestation or food scarcity. Our patent-pending cellulose bioparticles, can replace the US$10B of petrochemical and palm oil emulsifiers used in creams, lotions, drinks and foods every year. Using unusable wood from the timber industry, we can cut land use by 4-10x while avoiding cutting down more rainforests. Our bioparticles also increase product performance, unlock innovative new product formats, and halve the ingredient cost compared to existing emulsifiers.

Website: www.dotingredients.com
Contact: michael@dotingredients.com

BioOra Limited

Valid Investment Period expiry date: 7 August 2027
Total amount seeking: $45,000,000
Investment instrument: Issuing new shares (i.e. equity) 
Type of capital: Capital Expansion

BioOra is commercialising the world's first third-generation CAR-T therapy, reprogramming a patient's own immune cells to destroy blood cancers. Spanning New Zealand, Australia and into the US, BioOra owns an exclusive licence to Atla-cel and its entire manufacturing IP. With regulatory approvals advancing and vast unmet demand, BioOra offers investors early access to a high-growth manufacturing therapeutics company: proven manufacturing, a world-leading CAR-T, and a direct line of sight to patient delivery, regionally and globally.

Website: www.bioora.com
Contact: john.robson@bioora.com

Atlas Finance Ltd (trading as Atlas Finance)

Valid Investment Period expiry date: 8 June 2027 
Total amount seeking: $30,000,000 
Investment instrument: Issuing new shares (i.e. equity) 
Type of capital: Other business or project activity

We lend to businesses on trucks, diggers, dozers, tractors, harvesters, forklifts, plant and equipment – working assets, generating income and cashflow for businesses across New Zealand. The sector is forecast to grow by $25 billion in the next ten years, and Atlas Finance will be part of that growth. The principals are highly experienced and understand what success looks like.

Website: http://www.atlasfinance.co.nz/aip-invest 
Contact: francis@atlasfinance.co.nz

HikoTerra Limited

Valid Investment Period expiry date: 8 June 2027 
Total amount seeking: $4,500,000 
Investment instrument: Issuing new shares (i.e. equity) 
Type of capital: Start-up capital

We have been developing a hybrid power system for vessel and vehicle builders, installers, and users, designed to reduce complexity and cost. With a battery-first approach, HikoTerra lowers reliance on generators while enabling cleaner, quieter operation. Backed by experienced founders, investors, and proven industry leaders, the technology is market-ready. With much of the groundwork complete, we are now seeking investment to launch commercially and execute our roadmap and future expansion.

Website: www.hikoterra.com  
Contact: mark.harnett@hikoterra.com

Insitugen Limited

Valid Investment Period expiry date: 29 April 2027 
Total amount seeking: $2,000,000 
Investment instrument: Issuing new shares (i.e. equity) 
Type of capital: Growth capital

With the world’s first low-cost test for the detection of androgen and estrogen bioactivity, InsituGen is developing cell-free bioassay technology to reinvent steroid hormone testing in companion animal diagnostics.

Website: www.insitugen.com
Contact: matt@insitugen.com

Tiger Fintech (NZ) Limited

Valid Investment Period expiry date: 21 May 2027 
Total amount seeking: $20,000,000
Investment instrument: Issuing new shares (i.e. equity) 
Type of capital: Growth Capital

Tiger Fintech (NZ) Ltd (TFNZ), a subsidiary of a Nasdaq-listed company, has established itself as a trusted name in the New Zealand financial market for over 10 years, providing New Zealand investors with access to global stock markets. TFNZ provides a seamless, secure, and cost-effective online trading platform, enabling clients to trade equities across both New Zealand and international markets. This is an opportunity for investors to back TFNZ's next phase of growth — expanding its footprint across New Zealand's key regions and driving continued innovation through new products on the trading platform.

Website: www.tigerbrokers.nz
Contact: clientservices@tigerbrokers.nz

Wolfe Heritage Hotel No.1 Limited (trading as Wolfe Heritage Hotel)

Valid Investment Period expiry date: 22 April 2027 
Total amount seeking: $6,500,000 
Investment instrument: Issuing new shares (i.e. equity) 
Type of capital: Greenfields Project

Invest in a new luxury hotel in the heart of Auckland’s downtown waterfront. The Hotel is managed by a well-known international hotel group. Real estate asset backed investment: ownership of a freehold strata hotel unit and management shares through your own AIP visa approved investment company. Your investment company will be managed by Conrad Funds Management Limited. Funds count for AIP visa purposes upon payment and investment in the solicitor’s stakeholder trust account. The hotel will be developed by a leading New Zealand property developer, Conrad Properties Group.

Website: www.wolfeheritagehotel.com 
Contact: info@wolfeheritagehotel.com

YY Nation

Valid Investment Period expiry date: 16 March 2027 
Total amount seeking: $3,500,000 
Investment instrument: Issuing new shares (i.e. equity) 
Type of capital: Growth capital

YY Nation is a New Zealand-founded consumer brand operating in the global sustainable footwear sector. Combining innovative plant-based materials with modern design and performance, the company has achieved early market validation through major international retail partners including Nordstrom and Zumiez. Seeking US$3 million of growth capital, YY Nation is positioned to scale distribution and capture a share of the multi-billion-dollar sustainable footwear market while building a globally recognised New Zealand brand.

Website: www.yynation.co.nz
Contact: michael.vukcevic@fidelitycp.nz

Leaft Foods Holdings Limited

Valid Investment Period expiry date: 10 March 2027 
Total amount seeking: $16,000,000 
Investment instrument: Convertible loan note 
Type of capital: Growth capital

Leaft has developed the world’s first industrially scalable platform to extract Rubisco, a highly nutritious and functional protein that outperforms whey and egg. Operating at commercial scale in a 30,000 sq. ft facility, Leaft has launched its first products, the Leaft Blade and award-winning ingredient Rubisco Protein Isolate. Leaft is led by a team of proven business builders, including the founder of a prior US$1 billion+ NZX-listed nutrition company.

Website: www.leaftfoods.com 
Contact: chris.simcock@leaftfoods.com

Pegasus Bloodstock LP

Valid Investment Period expiry date: 14 January 2027 
Total amount seeking: $10,000,000 
Investment instrument: Issuing new shares (i.e. equity) 
Type of capital: Capital expansion

Pegasus Bloodstock LP is a New Zealand-based thoroughbred breeding and bloodstock investment platform focused on developing high-quality breeding assets and related infrastructure. Through investment in breeding operations, farm development and international market access, the partnership supports export growth, skilled employment and regional economic development. Pegasus provides investors exposure to New Zealand's globally recognised thoroughbred breeding industry through a professionally managed, growth-oriented investment platform.

Website: www.pblp.co.nz 
Contact: info@taniwhagroup.com

Syndex Group Limited

Valid Investment Period expiry date: 23 December 2026 
Total amount seeking: $1,000,000 
Investment instrument: Issuing new shares (i.e. equity) 
Type of capital: Growth capital

Syndex is reshaping private capital markets, connecting private capital (including AIP investors) to exciting private investment opportunities and supporting investor relations with cutting-edge, cloud-based software that includes unique and contemporary secondary market trading capability. Private markets are the fastest growing asset class globally and Syndex works with fund managers, businesses, ESOPs and co-operatives to efficiently access capital and with investors including to digitally manage their portfolio and unlock liquidity if required.

Website: www.syndex.exchange 
Contact: ross.verry@syndex.exchange

Compostify Limited

Valid Investment Period expiry date: 22 December 2026 
Total amount seeking: $2,500,000 
Investment instrument: Issuing new shares (i.e equity) 
Type of capital: Start-up capital

Compostify is a New Zealand biomaterials platform company developing certified biodegradable alternatives to conventional plastics. Protected by proprietary formulations and intellectual property, its technology has applications across agriculture, horticulture, marine, construction, packaging and 3D printing markets. As global regulations increasingly target plastic pollution, microplastics and misleading environmental claims, Compostify offers scalable solutions that combine performance with verified end-of-life sustainability.

Website: www.compostify.com 
Contact: peter@compostify.com

Apercure Surgical Limited

Valid Investment Period expiry date: 11 December 2026 
Total amount seeking: $4,500,000 
Investment instrument: Issuing new shares (i.e. equity) 
Type of capital: Growth capital

Apercure Surgical is a New Zealand-based medical device company developing innovative technologies that address unmet needs across the global healthcare market. Our lead product, LIMPIT®, is an IP-protected, scalable wound management and catheter securement platform designed to improve patient outcomes, reduce complications, and simplify clinical workflows. Having successfully completed clinical trials, Apercure is preparing for US market entry, targeting the multi-billion-dollar wound management and drainage catheter markets while advancing its broader product pipeline.

Website: www.apercure.com 
Contact: g.watts@apercure.com

Note: Companies on this part of the list may or may not have third-party genuine investors. However, this factor did not form part of the relevant assessment criteria at the time the application was considered.

The Sustainable Care Company Limited

Valid Investment Period expiry date: 27 February 2027
Total amount seeking: $5,000,000
Investment instrument: Simple Agreement for Future Equity (SAFE)
Type of capital: Growth Capital

Cleanery makes cleaning and personal care products as concentrated powder. Add water at home: more effective products, no shipping water, 99% less waste and emissions, much lower costs than traditional products.
The technology is the business. Formulations and manufacturing systems built in-house, patent-pending, and validated: On-shelf in 2500+ stores, and a global corporate, amongst others, has chosen our platform over their own for their entire cleaning range across 80+ markets.

Website: https://www.cleaneryonline.com/
Contact: ms@cleanery.co.nz

Mini Mall Group LTD

Valid Investment Period expiry date: 27 February 2027
Total amount seeking: $5,000,000 
Investment instrument: Issuing new shares (i.e. equity) 
Type of capital: Growth Capital

Mini Mall Group is a New Zealand-based technology-driven commerce platform connecting local businesses, consumers, and digital services. Through its online marketplace, payment infrastructure, and AI-powered business tools, the company helps small and medium-sized enterprises improve operational efficiency and customer growth. With an established business foundation, Mini Mall Group is expanding into AI-enabled solutions designed to support the next generation of community commerce.

Website: https://mmallgroup.com/
Contact: rock@sentribee.ai

Inhibit Coatings Limited (trading as Argentix)

Valid Investment Period expiry date: 22 February 2027 
Total amount seeking: $2,000,000 
Investment instrument: Issuing new shares (i.e. equity) 
Type of capital: Start-up capital

At Argentix (formerly Inhibit Coatings) we address the critical need for infection protection within the orthopedic market. As a leader in antimicrobial material science, our proprietary polymer platform technology represents the first cost-effective, high-performance antimicrobial solution engineered to optimize clinical outcomes for high-infection-risk procedures.

Website: www.argentixmed.com
Contact: eldon.tate@argentixmed.com

Kauri Senior Care Limited

Valid Investment Period expiry date: 17 December 2026 
Total amount seeking: $31,500,000 
Investment instrument: Convertible loan note 
Type of capital: Start-up capital

Kauri Care Limited is a specialized New Zealand aged care provider focused on high-acuity, hospital-level facilities supported by ARRC funding. Managing the full lifecycle from development to clinical operations, we integrate proprietary facility design with a dedicated vocational training pipeline. This unified approach ensures sustainable staffing, rigorous quality control, and scalable, high-quality care delivery across our entire portfolio.

Website: www.kauricare.co.nz 
Contact: info@kauricare.co.nz

Kauri Senior Care Remuera Limited

Valid Investment Period expiry date: 17 December 2026 
Total amount seeking: $30,200,000 
Investment instrument: Convertible loan note 
Type of capital: Start-up capital

Kauri Care Limited is a specialized New Zealand aged care provider focused on high-acuity, hospital-level facilities supported by ARRC funding. Managing the full lifecycle from development to clinical operations, we integrate proprietary facility design with a dedicated vocational training pipeline. This unified approach ensures sustainable staffing, rigorous quality control, and scalable, high-quality care delivery across our entire portfolio.

Website: www.kauricare.co.nz 
Contact: don.wang@kauricare.co.nz

Hudson Villages Warkworth Limited

Valid Investment Period expiry date: 15 December 2026 
Total amount seeking: $45,000,000 
Investment instrument: Convertible loan note 
Type of capital: Greenfield project

Hudson Villages Warkworth Limited operates in the aged care sector and plans to establish a retirement village in Warkworth. This will consist of accommodation and wellness facilities, providing the physical environment where residents live and receive care. The development will contribute to the regional economy by increasing the value of underutilised land in Warkworth and provide for a premium retirement village.

Website: www.hudsonwarkworth.nz
Contact: jamie@tcap.nz

X Homes GP Limited

Valid Investment Period expiry date: 9 December 2026 
Total amount seeking: $25,000,000 
Investment instrument: Convertible loan note 
Type of capital: Growth capital

X Homes GP Limited is the parent company of Eden Management Holdings Limited, a company that designs, manufactures, and installs code-compliant standardised modular dwellings. With a strong commercial pipeline and a validated product-market, demand currently outstrips its capacity to manufacture. X Homes is aiming to raise capital via secured convertible loan notes to be used to support the growth and expansion of this exciting industry.

Website: www.xhomes.co.nz
Contact: info@xhomes.co.nz

Aspiring Limited Partnership

Valid Investment Period expiry date: 1 December 2026
Total amount seeking: $3,800,000 
Investment instrument: Other- United in Limited Partnership
Type of capital: Greenfields Project

Kiwifruit is one of NZ’s fastest growing export products. Aspiring LP is managed by Southern Cross Horticulture (SCH), a leading developer and operator of high performing SunGold kiwifruit orchards in the Bay of Plenty. To date, SCH has raised over $300m of capital to develop ~430 canopy hectares of kiwifruit orchards. Aspiring is SCH’s 7th LP, a 35.5 canopy hectare development with a projected pre-tax return for investors of +11%.

Website: www.southerncrosshorticulture.co.nz
Contact: ellie.lewis@schort.co.nz

Kiwi Ginseng Ltd (trading as KiwiSeng)

Valid Investment Period expiry date: 22 November 2026 
Total amount seeking: $10,000,000 
Investment instrument: Issuing new shares (i.e. equity) 
Type of capital: Capital expansion

Kiwi Ginseng Ltd (T/A KiwiSeng) is a leading New Zealand agritech and natural health company focused on premium forest-grown ginseng. Built over 18 years, it has developed distinctive cultivation expertise, advanced processing capability, and a high-value product portfolio. Independent scientific research shows exceptional active-compound levels, supporting its premium quality. Driven by rising global demand, KiwiSeng is positioned for scalable long-term growth through exports, smart farming, and wellness experiences.

Website: www.KiwiSeng.com 
Contact: glen@kiwiseng.com

Education 710+

Valid Investment Period expiry date: 7 November 2026 
Total amount seeking: $7,000,000 
Investment instrument: Issuing new shares (i.e. equity) 
Type of capital: Start-up capital

Investing in the NZ Education system through Education 710+ will provide both very good returns and the personal satisfaction to be a part of establishing state-of-the-art school(s) that will quickly be among NZ's very best. Led by Alwyn Poole, who has established six schools and is a high quality and respected leader in the sector. The initial school(s) will be in central Auckland and there is significant need.

Website: www.city0-10.co.nz
Contact: alwyn.poole@gmail.com

Kea Aerospace Limited (trading as Kea Aerospace)

Valid Investment Period expiry date: 7 November 2026 
Total amount seeking: $15,000,000 
Investment instrument: Issuing new shares (i.e. equity) 
Type of capital: Growth capital

Developing a fleet of solar-powered stratospheric aircraft that operate for months at a time, providing persistent, high-resolution aerial intelligence at a fraction of the cost and latency of satellites. Positioned between drones and space assets, our platform delivers continuous Earth observation for maritime surveillance, environmental monitoring, and defence capabilities. By creating an atmospheric satellite network, Kea Aerospace is building critical infrastructure for a more connected, secure, and sustainable world.

Website: www.keaaerospace.com 
Contact: mark@keaaerospace.com

Calm Pipe Holdings Limited (trading as Calmly)

Valid Investment Period expiry date: 22 October 2026 
Total amount seeking: $750,000 
Investment instrument: Issuing new shares (i.e. equity) 
Type of capital: Growth capital

Calmly is a non-addictive relaxation device providing a hand-to-mouth replacement for vaping and smoking and to reduce anxiety. Patented breathwork technology and high-quality natural aromas, foster diaphragm breathing without direct lung inhalation of active substances. After extensive R&D and market validation, Calmly will soon be ready for mass production and market launch. A dedicated and savvy founder seeks capital to accelerate this commercialization and maximise a first to market position.

Website: www.calmlyworld.com 
Contact: info@calmlyworld.com

Clearhead Limited (trading as Clearhead Limited)

Valid Investment Period expiry date: 22 October 2026 
Total amount seeking: $2,000,000 
Investment instrument: Issuing new shares (i.e equity) 
Type of capital: Growth capital

Clearhead is a leading ANZ workplace mental health EAP provider delivering evidence-based integrated solutions to hundreds of clients across small business to enterprise in all industries. Our AI-powered platform combines clinically-designed proactive tools, a vetted 1000+ therapist network, and psychosocial risk analytics. With 24/7 access to nationwide in-person and online therapy across both Australia and New Zealand, we enable early intervention and drive measurable ROI through improved employee resilience and psychological safety. Addressing the $1 trillion global mental health cost burden to employers while serving as a critical health and safety solution.

Website: www.myclearhead.com 
Contact: angela.lim@myclearhead.com

Kauri Henderson Holding Limited

Valid Investment Period expiry date: 22 October 2026 
Total amount seeking: $80,800,000 
Investment instrument: Convertible loan note i.e. debt that can be converted into equity 
Type of capital: Growth capital

Kauri Senior Care is developing a 146-bed, high-acuity hospital-level aged care facility in Henderson, Auckland. The project operates under an integrated clinical model, with revenue supported by government-funded ARRC (Age-Related Residential Care) contracts. By incorporating a dedicated vocational training pipeline for clinical staff, the project maintains standardized operational parameters and aims to deliver consistent long-term financial performance within the New Zealand aged care sector.

Website: www.kauricare.co.nz 
Contact: info@kauricare.co.nz

Parkhelp Technologies Ltd (trading as Parkhelp)

Valid Investment Period expiry date: 26 September 2026 
Total amount seeking: $10,000,000
Investment instrument: Equity (i.e issuing new shares) and Convertible Note (i.e debt that can be converted into equity)  
Type of capital: Growth capital

Parking is a US$1 trillion industry running on outdated infrastructure—and ParkHelp is rebuilding it with Physical AI. With 700+ customers across 50+ countries supported from our 5 subsidiaries, we're in our third straight year of 100% YoY growth. We've completed a $10m first close on our $15m round to drive our global operations and acquisitions—including c.$4m from five investor visa applicants from the US and Europe.

Website: www.parkhelp.com
Contact: investor@parkhelp.com